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Background
• Non-alcoholic fatty liver disease (NAFLD) is the most
prominent liver disease in the world
• Non-alcoholic steatohepatitis (NASH) is defined when
inflammation is associated with hepatic steatosis
• Methionine/choline deficient (MCD) diet induced
NASH in mice model
• Methylation is the addition of a methyl group (CH3) at
CpG dinucleotide sites (DMNTs)
• DNA methylation = gene silencer (hypermethylation
associated with NASH pathology)
• Cannabigerol (CBG) = a non-psychotropic cannabinoid
• Experimental conditions = MCD, MCD Low CBG, MCD




• DNA extracted from liver tissue
2. Bisulfite treatment
• Distinguish the methylated and unmethylated cytosine
3. MSP
• Methylation-specific polymerase chain reaction




• Indicated either hypomethylation or hypermethylation 
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Gene NAFLD pathology relation
1. PNPLA3: Encodes lipase protein
• Catabolic activity towards triglycerides
2. CDKN1A: Encodes p21 protein
• Transcriptional p53 target, cell cycle inhibitor, 
and cellular senescence
3. BMAL1: Encodes circadian clock protein
• Fat storage/utilization and adipocyte 
differentiation
4. NR1C3: Encodes PPAR-γ protein
• Lipid metabolism and adipocyte differentiation
Methylation-specific PCR (MSP) – PNPLA3
Future Direction
• PNPLA3 gene: Hypomethylation
• CDKN1A gene: NA
• BMAL1 gene: NA
• NR1C3 gene: NA
Hypothesis 1: For PNPLA3, this 
hypothesis is rejected
Hypothesis 2: For PNPLA3, this 
hypothesis is accepted (High CBG only)
• Only had time to collect data for 
PNPLA3 gene
• In the groups with no CBG, MCD diet 
hypomethylated PNPLA3 gene 
compared to Control diet 
• In the groups with High CBG, the 
PNPLA3 gene was hypomethylated (not 
Low CBG groups) 
• Gather data on CDKN1A, BMAL1, and 
NR1C3
• Investigate the role of cannabinoids, 
such as CBG, in alleviating the damage 
caused by MCD diet
• Explore whether CBG could be a 
potential therapeutic approach for 
NAFLD patients 
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Figure 1: Gel-electrophoresis data for PNPLA3 gene. Each experimental condition had two 
mouse samples. Each mouse sample was PCR amplified for both methylated and 
unmethylated version of PNPLA3 gene. The “M” signifies the methylated sample, and the 
”U” signifies the unmethylated sample. 
Research question: what is the 
hypo/hypermethylation effect on promoter regions 
of CDKN1A, BMAL1, NR1C3, and PNPLA3 genes with 
CBG implementation utilizing a mouse model with 
MCD diet to induce NASH?
Hypothesis 1: MCD diet will hypermethylate the 
four genes compared to the control diet
Hypothesis 2: CBG implementation will 
hypomethylate the four genes
